Novartis AG (BCBA:NVS)

Market Cap	368.19T
Revenue (ttm)	77.26T
Net Income (ttm)	19.73T
Shares Out	n/a
EPS (ttm)	10,003.28
PE Ratio	18.67
Forward PE	15.35
Dividend	624.65 (1.24%)
Ex-Dividend Date	Mar 12, 2025

Volume	9
Average Volume	182
Open	50,325
Previous Close	50,625
Day's Range	50,200 - 50,350
52-Week Range	26,525 - 53,300
Beta	n/a
RSI	56.33
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD